Evidência
Esta página contém um quadro momentâneo do conteúdo que destaca evidências que abordam questões clínicas importantes, incluindo áreas de incerteza. Consulte a lista de referências principal do tópico para obter mais detalhes sobre todas as fontes que embasam este tópico.
Respostas Clínicas Cochrane
As Respostas Clínicas Cochrane (RCCs) proporcionam um ponto de entrada amigável, digerível e clinicamente focado para as pesquisas rigorosas das revisões sistemáticas Cochrane. Elas são desenvolvidas para serem acionáveis e para respaldar a tomada de decisão no local de atendimento, e foram adicionadas a seções relevantes do texto principal do Best Practice.
- What are the effects of interventions to improve inhaler technique in children with asthma?
- In children with chronic asthma, what are the benefits and harms of adding long-acting beta2-agonists compared with adding anti-leukotrienes to inhaled corticosteroids?
- How do anti-leukotriene agents compare with inhaled corticosteroids in the management of recurrent and/or chronic asthma in children?
- How does ciclesonide compare with other inhaled corticosteroids in children and adolescents with chronic asthma?
- What adverse events are associated with formoterol when used for the regular treatment of chronic asthma?
- What are the benefits and harms of adding anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma?
- For children with asthma, can exhaled nitric oxide levels help to guide treatment?
- What are the benefits and harms of home telemonitoring and remote feedback between clinic visits in people with asthma?
- What are the effects of home‐based educational interventions for children with asthma?
- What are the effects of school‐based interventions for children and adolescents with asthma?
- Does asthma education for school staff benefit children with asthma?
- In people with mild to moderate asthma, how do flu vaccines affect asthma symptoms?
O uso deste conteúdo está sujeito ao nosso aviso legal